Filing Details
- Accession Number:
- 0001596783-23-000056
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-03 16:30:22
- Reporting Period:
- 2023-08-01
- Accepted Time:
- 2023-08-03 16:30:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1596783 | Catalent Inc. | CTLT | Pharmaceutical Preparations (2834) | 208737688 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1792807 | J Michael Grippo | C/O Catalent, Inc. 14 Schoolhouse Road Somerset NJ 08873 | Svp, Strategy & Corp. Dev. | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-08-01 | 35 | $46.64 | 17,757 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-08-01 | 241 | $47.88 | 17,516 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-08-01 | 6,209 | $0.00 | 23,725 | No | 4 | A | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | A | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Options to purchase Common Stock | Acquisiton | 2023-08-01 | 13,830 | $0.00 | 13,830 | $46.51 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 13,830 | 2033-08-01 | No | 4 | A | Direct |
Footnotes
- Shares sold by the reporting person through an automatic "sell-to-cover" transaction to cover tax withholding obligations in connection with the vesting of restricted stock units received pursuant to the Issuer's long-term incentive plan. No shares were withheld by or surrendered to the Issuer.
- Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $46.22 to $47.19, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- Includes restricted stock units.
- Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $47.26 to $48.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- Restricted stock units received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan. Each restricted stock unit represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur in three equal annual installments beginning on August 1, 2024.
- Received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan.
- The options vest and become exercisable in four equal annual installments beginning on August 1, 2024.
Billionaire Hedge Funds
